13 July,2021 01:58 PM IST | New Delhi | PTI
Photo for representational purpose
Serum Institute of India (SII) will start production of Sputnik vaccine at the company's facilities in September, Russian Direct Investment Fund (RDIF) said on Tuesday.
"The first batch of Sputnik vaccine is expected to be produced at SII's facilities in September," RDIF said in a statement.
The parties intend to produce over 300 million doses of the vaccine in India per year, it added.
"As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun," RDIF said.
ALSO READ
Mumbai: Delayed adult TB vaccine survey in city likely to begin soon
Israeli strikes in Gaza kill more than a dozen as health workers press on with polio vaccines
Online vaccine management portal U-Win to be launched later this month: Union health secretary
First 100,000 doses of mpox vaccine reach Congo. But it's fraction of what is needed
The first 100,000 doses of mpox vaccine reach Congo. But it's a fraction of what is needed
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.
